Akston Biosciences Corporation announced that the first participants have been dosed in an open-label trial of AKS-452, its COVID-19 vaccine candidate.
Akston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Akston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Cathie Wood’s Top 5 Stock Picks and ARK Portfolio Updates
In this article we will take a look at some of the top stocks picks of Cathie Wood from the sectors she is bullish on. To read our detailed analysis of ARK’s performance and Cathie Wood’s latest comments on the market, go to Cathie Wood’s Strong Comeback: ARK’s Latest Stock Picks, Portfolio Updates and Comments
5. Twist Bioscience Corporation (NASDAQ: TWST)
Twist Bioscience makes synthetic DNA for clients in the biotechnology industry. It is also known for an advanced liquid handling robot technology that builds DNA in the microplates. In March, the FDA approved the company’s SARS-CoV-2 next-generation sequencing assay. The assay can analyze the entire RNA viral sequence and generate reports to analyze RNA sequence to detect genetic variants and lineages of SARS-CoV-2.
Cathie Wood s Top 10 Stock Picks yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.